Literature DB >> 20309514

[Dermatologic-psychosomatic rehabilitation].

J Wehrmann1.   

Abstract

Dermatologic-psychosomatic rehabilitation is indicated when a patient has both cutaneous and psychological disease, as well as when psychosocial factors have a negative influence on the course of disease or coping mechanisms. The goals of multimodal dermatologic and psychotherapeutic treatment are increased empowerment and self-action, as well as acceptance of disability. Requirements for admission are given with regard to ICF. The course of rehabilitation is explained and the most important therapeutic tools are presented.

Entities:  

Mesh:

Year:  2010        PMID: 20309514     DOI: 10.1007/s00105-009-1865-3

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  8 in total

1.  [Effects of combined dermatological and behavioural medicine therapy in hospitalized patients with psoriasis and atopic dermatitis].

Authors:  S Lange; I Zschocke; S Langhardt; U Amon; M Augustin
Journal:  Hautarzt       Date:  1999-11       Impact factor: 0.751

2.  [The international classification of functioning, disability and health (ICF) in dermatological rehabilitation: conception, application, perspective].

Authors:  H H Niederauer; G Schmid-Ott; N Buhles
Journal:  Hautarzt       Date:  2005-07       Impact factor: 0.751

3.  [Pathogenesis of atopic eczema].

Authors:  Natalija Novak; Thomas Bieber
Journal:  J Dtsch Dermatol Ges       Date:  2005-12       Impact factor: 5.584

4.  [Psychosocial consequences of psoriasis--an empirical study of disease burden in 3753 affected people].

Authors:  G Schmid-Ott; P Malewski; I Kreiselmaier; U Mrowietz
Journal:  Hautarzt       Date:  2005-05       Impact factor: 0.751

5.  [Psychosomatic disorders in dermatology--incidence and need for added psychosomatic treatment].

Authors:  C M Schaller; L Alberti; G Pott; T Ruzicka; W Tress
Journal:  Hautarzt       Date:  1998-04       Impact factor: 0.751

Review 6.  [Inpatient behavioral medicine in chronic skin diseases].

Authors:  L Hoegl; M Fichter; G Plewig
Journal:  Hautarzt       Date:  1998-04       Impact factor: 0.751

7.  [Atopic dermatitis and stress? How do emotions come into skin?].

Authors:  A V Mitschenko; A N Lwow; J Kupfer; V Niemeier; U Gieler
Journal:  Hautarzt       Date:  2008-04       Impact factor: 0.751

8.  Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study.

Authors:  Sonja Ständer; Barbara Böckenholt; Funda Schürmeyer-Horst; Carsten Weishaupt; Gereon Heuft; Thomas A Luger; Gudrun Schneider
Journal:  Acta Derm Venereol       Date:  2009       Impact factor: 4.437

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.